A detailed history of Strs Ohio transactions in Arvinas, Inc. stock. As of the latest transaction made, Strs Ohio holds 4,900 shares of ARVN stock, worth $93,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,900
Previous 4,900 -0.0%
Holding current value
$93,491
Previous $130,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$36.38 - $52.31 $716,686 - $1.03 Million
-19,700 Reduced 80.08%
4,900 $202,000
Q4 2023

Jan 30, 2024

SELL
$14.19 - $42.33 $62,436 - $186,252
-4,400 Reduced 15.17%
24,600 $1.01 Million
Q3 2023

Oct 26, 2023

BUY
$19.64 - $28.21 $229,788 - $330,057
11,700 Added 67.63%
29,000 $569,000
Q2 2023

Jul 31, 2023

BUY
$21.73 - $31.43 $126,034 - $182,294
5,800 Added 50.43%
17,300 $429,000
Q1 2023

Aug 02, 2023

SELL
$26.15 - $37.26 $151,670 - $216,108
-5,800 Reduced 33.53%
11,500 $314,000
Q3 2022

Oct 27, 2022

SELL
$41.87 - $57.99 $125,609 - $173,970
-3,000 Reduced 20.69%
11,500 $511,000
Q2 2022

Jul 25, 2022

SELL
$36.01 - $74.24 $10,803 - $22,272
-300 Reduced 2.03%
14,500 $610,000
Q1 2022

Apr 21, 2022

BUY
$60.27 - $81.57 $385,728 - $522,047
6,400 Added 76.19%
14,800 $996,000
Q4 2021

Jan 24, 2022

SELL
$65.85 - $96.21 $72,435 - $105,831
-1,100 Reduced 11.58%
8,400 $689,000
Q3 2021

Oct 22, 2021

BUY
$73.2 - $107.87 $73,200 - $107,870
1,000 Added 11.76%
9,500 $780,000
Q2 2021

Jul 26, 2021

BUY
$60.45 - $84.26 $459,420 - $640,376
7,600 Added 844.44%
8,500 $654,000
Q1 2021

Apr 23, 2021

BUY
$58.19 - $91.37 $52,371 - $82,233
900 New
900 $59,000
Q4 2020

Jan 25, 2021

SELL
$20.19 - $84.93 $377,553 - $1.59 Million
-18,700 Closed
0 $0
Q3 2020

Dec 14, 2020

SELL
$22.99 - $36.34 $32,185 - $50,876
-1,400 Reduced 6.97%
18,700 $441,000
Q2 2020

Jul 23, 2020

BUY
$29.88 - $56.74 $161,352 - $306,396
5,400 Added 36.73%
20,100 $674,000
Q1 2020

Apr 23, 2020

SELL
$33.0 - $54.5 $125,400 - $207,100
-3,800 Reduced 20.54%
14,700 $592,000
Q4 2019

Jan 24, 2020

BUY
$15.39 - $44.38 $163,134 - $470,428
10,600 Added 134.18%
18,500 $760,000
Q3 2019

Oct 21, 2019

BUY
$21.55 - $27.61 $124,990 - $160,138
5,800 Added 276.19%
7,900 $170,000
Q4 2018

Jan 23, 2019

BUY
$11.19 - $18.56 $23,499 - $38,976
2,100 New
2,100 $26,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.